Literature DB >> 12708811

Can the Expanded Disability Status Scale be assessed by telephone?

J Lechner-Scott1, L Kappos, M Hofman, C H Polman, H Ronner, X Montalban, M Tintore, M Frontoni, C Buttinelli, M P Amato, M L Bartolozzi, M Versavel, F Dahlke, J-F Kapp, R Gibberd.   

Abstract

Information from patients who are unable to continue their visits to a study centre may be of major importance for the interpretation of results in multiple sclerosis (MS) clinical trials. To validate a questionnaire based on the Expanded Disability Status Scale (EDSS), patients in five different European centres were assessed independently by pairs of trained EDSS raters, first by telephone interview and a few days later by standardized neurological examination. Seventy women and 40 men with an average age of 43.7 years (range 19-74 years) were included in the study. Mean EDSS score at the last visit was 4.5 (0-9). EDSS assessment by telephone was highly correlated with the EDSS determined by physical examination (Pearson's correlation coefficient = 0.95). An intraclass correlation coefficient (ICC) of 94.8% was found for the total sample; 77.6% and 86%, respectively, for patients with EDSS < 4.5 (n = 46) and > 4.5 (n = 64). Kappa values for full agreement were 0.48; for variation by +0.5 steps and +1.0 steps, 0.79 and 0.90, respectively. Best agreement could be found in higher EDSS scores, where assessment by telephone interview might be needed most. The telephone questionnaire is a valid tool to assess EDSS score in cases where the patient is unable to continue visiting a study centre or in long-term follow-up of trial participants.

Entities:  

Mesh:

Year:  2003        PMID: 12708811     DOI: 10.1191/1352458503ms884oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  36 in total

1.  Walking function in clinical monitoring of multiple sclerosis by telemedicine.

Authors:  Núria Sola-Valls; Yolanda Blanco; Maria Sepúlveda; Sara Llufriu; Elena H Martínez-Lapiscina; Delon La Puma; Francesc Graus; Pablo Villoslada; Albert Saiz
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

2.  Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.

Authors:  S J Pittock; R L McClelland; S J Achenbach; F Konig; A Bitsch; W Brück; H Lassmann; J E Parisi; B W Scheithauer; M Rodriguez; B G Weinshenker; C F Lucchinetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.

Authors:  Sara Leddy; Shahrzad Hadavi; Andrew McCarren; Gavin Giovannoni; Ruth Dobson
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

4.  A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?

Authors:  Marina Katsari; Dimitrios S Kasselimis; Erasmia Giogkaraki; Marianthi Breza; Maria-Eleftheria Evangelopoulos; Maria Anagnostouli; Elisabeth Andreadou; Costas Kilidireas; Alia Hotary; Ioannis Zalonis; Georgios Koutsis; Constantin Potagas
Journal:  J Neurol       Date:  2020-02-01       Impact factor: 4.849

5.  Telemedicine for Monitoring MS Activity and Progression.

Authors:  Nuria Sola-Valls; Yolanda Blanco; Maria Sepúlveda; Eugenia Martinez-Hernandez; Albert Saiz
Journal:  Curr Treat Options Neurol       Date:  2015-11       Impact factor: 3.598

6.  Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis.

Authors:  Hanneke E Hulst; Menno M Schoonheim; Stefan D Roosendaal; Veronica Popescu; Lizanne J S Schweren; Ysbrand D van der Werf; Leo H Visser; Chris H Polman; Frederik Barkhof; Jeroen J G Geurts
Journal:  Hum Brain Mapp       Date:  2011-09-06       Impact factor: 5.038

7.  T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

Authors:  B Bodini; M Battaglini; N De Stefano; Z Khaleeli; F Barkhof; D Chard; M Filippi; X Montalban; C Polman; M Rovaris; A Rovira; R Samson; D Miller; A Thompson; O Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

8.  Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.

Authors:  Mike Boggild; Jackie Palace; Pelham Barton; Yoav Ben-Shlomo; Thomas Bregenzer; Charles Dobson; Richard Gray
Journal:  BMJ       Date:  2009-12-02

9.  Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.

Authors:  Rosa E Boeschoten; Joost Dekker; Bernard M J Uitdehaag; Chris H Polman; Emma H Collette; Pim Cuijpers; Aartjan T F Beekman; Patricia van Oppen
Journal:  BMC Psychiatry       Date:  2012-09-11       Impact factor: 3.630

10.  Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.

Authors:  Yvonne C Learmonth; Robert W Motl; Brian M Sandroff; John H Pula; Diego Cadavid
Journal:  BMC Neurol       Date:  2013-04-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.